The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin.
[rubitecan co-treated with Phosphatidylcholines] results in increased expression of AIFM1 protein rubitecan results in increased expression of AIFM1 protein
[rubitecan co-treated with Phosphatidylcholines] results in increased expression of BAX protein rubitecan results in increased expression of BAX protein
[rubitecan co-treated with Phosphatidylcholines] results in decreased expression of BCL2 protein rubitecan results in decreased expression of BCL2 protein
[rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP3 protein rubitecan results in increased expression of CASP3 protein
[rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP8 protein rubitecan results in increased expression of CASP8 protein
rubitecan results in increased expression of CASP9 protein [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CASP9 protein
[rubitecan co-treated with Phosphatidylcholines] results in decreased expression of CCND1 protein rubitecan results in decreased expression of CCND1 protein
[rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1A protein rubitecan results in increased expression of CDKN1A protein
rubitecan results in increased expression of CDKN1B protein [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1B protein